52061-75-3 Usage
Description
2,2-DIPROPYLPENTANOIC ACID, also known as 2-Propyl valproate, is a quaternary carbon compound with potential applications in the medical field. It is characterized by its unique chemical structure, which allows it to interact with biological systems in various ways.
Uses
Used in Pharmaceutical Industry:
2,2-DIPROPYLPENTANOIC ACID is used as a musculotropic and neurotropic antispasmodic agent for its potential to alleviate muscle spasms and neurological disorders. Its chemical properties enable it to interact with biological systems, making it a promising candidate for the development of new medications.
Used in Musculoskeletal Applications:
2,2-DIPROPYLPENTANOIC ACID is used as a treatment for muscle spasms and related conditions due to its musculotropic properties. It may help to relax muscles and reduce pain associated with spasms, providing relief for patients suffering from these conditions.
Used in Neurological Applications:
2,2-DIPROPYLPENTANOIC ACID is used as a treatment for neurological disorders due to its neurotropic properties. It may help to alleviate symptoms associated with certain neurological conditions, such as epilepsy or other seizure disorders, by modulating the activity of neurons in the brain.
Check Digit Verification of cas no
The CAS Registry Mumber 52061-75-3 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 5,2,0,6 and 1 respectively; the second part has 2 digits, 7 and 5 respectively.
Calculate Digit Verification of CAS Registry Number 52061-75:
(7*5)+(6*2)+(5*0)+(4*6)+(3*1)+(2*7)+(1*5)=93
93 % 10 = 3
So 52061-75-3 is a valid CAS Registry Number.
InChI:InChI=1/C11H22O2/c1-4-7-11(8-5-2,9-6-3)10(12)13/h4-9H2,1-3H3,(H,12,13)
52061-75-3Relevant articles and documents
Late-Stage β-C(sp3)-H Deuteration of Carboxylic Acids
Mal, Sourjya,Uttry, Alexander,Van Gemmeren, Manuel
supporting information, p. 10895 - 10901 (2021/08/03)
Carboxylic acids are highly abundant in bioactive molecules. In this study, we describe the late-stage β-C(sp3)-H deuteration of free carboxylic acids. On the basis of the finding that C-H activation with our catalysts is reversible, the de-deuteration process was first optimized. The resulting method uses ethylenediamine-based ligands and can be used to achieve the desired deuteration when using a deuterated solvent. The reported method allows for the functionalization of a wide range of free carboxylic acids with diverse substitution patterns, as well as the late-stage deuteration of bioactive molecules and related frameworks and enables the functionalization of nonactivated methylene β-C(sp3)-H bonds for the first time.
